Oxytocin: the basics
What is it?
A natural hormone involved in uterine contractions and milk release. Prescription oxytocin is used mainly in maternity care.
Research paper 1 ↗Prescribing information 2 ↗What do people claim it helps with?
Labor management and postpartum bleeding control are medical uses. Claims about trust, bonding, mood or autism treatment are separate and do not follow from those approvals.
What has research actually shown?
Established clinical use supports specified obstetric applications. A large controlled trial of nasal oxytocin in children and adolescents with autism did not show a significant improvement on its main social-function measure.
Research paper 1 ↗Prescribing information 2 ↗Has this been demonstrated in people?
Demonstrated in people, including controlled clinical trials for the uses described here. Evidence for one diagnosis does not establish benefit for every other claim.
Research paper 1 ↗Prescribing information 2 ↗What side effects, risks and unknowns should I understand?
Excessive uterine contractions can harm the mother or baby. Water intoxication, low blood sodium and cardiovascular effects are other concerns; obstetric use requires close monitoring.
Prescribing information ↗Is it an approved medicine?
Yes. Injectable oxytocin has FDA-approved obstetric uses. It is not FDA-approved as a nasal treatment for bonding, mood or autism.
Prescribing information ↗Approval here means U.S. FDA approval and applies to a particular product, formulation and use. This is a starting overview, not a complete side-effect list. Sources checked 10 October 2026; independent scientific review pending.
How is it used or studied?
Medical injection or infusion in monitored care. Experimental nasal use is a different context.
Different routes and formulations can have different effects. A study of one product does not validate every product with the same peptide name.
A common misunderstanding
A naturally occurring hormone can still cause harm when administered as a medicine.
What should I ask a clinician?
- What diagnosis or goal are we trying to address, and what established options are available?
- Was the expected benefit shown in people like me, using this exact product?
- How could my medicines, health conditions or pregnancy plans affect the risks?
- What monitoring is needed, and what would tell us the treatment is helping or should be stopped?
What do the research words mean?
- Peptide
- A short chain of amino acids, the building blocks of proteins.
- Preclinical
- Research in cells, tissues or animals before dependable treatment evidence in people.
- Controlled trial
- A study comparing a treatment with another treatment or a placebo to help separate its effects from other explanations.
- Biomarker
- A measurement, such as a hormone level. A change does not necessarily mean someone feels better or lives longer.
Oxytocin Evidence & Clinical Profile
Established Clinical Trials
Oxytocin has been investigated in clinical contexts. Patient outcomes must be evaluated against study size, design, and control cohorts.
Laboratory & In Vivo Assays
Cellular and animal disease models examine receptor binding affinities and signaling cascades, which require human confirmation.
What is Oxytocin?
Oxytocin (Pitocin) is An endogenous cyclic nonapeptide synthesized in the hypothalamus and released from the posterior pituitary. Extensively utilized in obstetrics for labor induction and postpartum hemorrhage prevention, and investigated in psychiatric neuroscience for prosocial bonding. Aliases include: Pitocin, Syntocinon, Endogenous nonapeptide neurohormone.
- Sequence (one-letter)
- CYIQNCPLG-NH2
- Molecular formula
- C43H66N12O12S2
- Molecular weight
- 1007.2 g/mol
- CAS Number
- 50-56-6
- UNII Code
- 1JQS135EYN
- PubChem CID
- 439302
Identifiers are for the free base; oxytocin acetate carries UNII 4NR672T8NL.
Identifiers checked against PubChem and FDA's Global Substance Registration System on 13 October 2026. FDA substance record ↗ · PubChem record ↗ See all names and codes in the peptide name index.
Clinical Trials & Human Cohorts
Human research can examine tolerability, symptoms or patient outcomes. The design and comparator determine what each result can establish.
Uterotonic Agents for Preventing Postpartum Hemorrhage: A Network Meta-Analysis [1]
What was reported
All uterotonic agents, including oxytocin, were effective for preventing PPH >= 500 mL versus placebo or no treatment; ergometrine plus oxytocin, misoprostol plus oxytocin and carbetocin ranked above oxytocin alone.
What limits the conclusion
Pooled trials varied in design and quality, and the certainty of several comparisons was rated low or moderate.
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder [2]
What was reported
No significant difference between intranasal oxytocin and placebo in social or cognitive functioning measures over 24 weeks.
What limits the conclusion
Failed to show clinical efficacy in large-scale blinded psychiatric trial.
How the compound may work
Mechanisms describe how Oxytocin may affect biological processes. Laboratory findings and patient outcomes answer different questions.
Gq-Coupled Uterine Contraction
Binds the oxytocin receptor, a class I G protein-coupled receptor coupled primarily via Gq proteins to phospholipase C-beta, stimulating uterine smooth muscle contraction during labor. [6]
Central Amygdala Modulation
In 15 healthy men, intranasal oxytocin reduced amygdala activation to fear-inducing visual stimuli and reduced amygdala coupling to brainstem regions. [4]
Areas Being Studied
These research topics reflect active areas of scientific exploration, distinct from unverified commercial marketing claims.
Compare the study designs.
| Study | Design / sample | Outcome type | Key limitation |
|---|---|---|---|
| WHO Uterotonic Guideline RCT · 2018 [1] | Cochrane Systematic Review & Meta-Analysis n = 135559 |
Clinical endpoint evaluation | Pooled trials varied in design and quality, and the certainty of several comparisons was rated low or moderate. |
| Intranasal Autism Trial · 2021 [2] | Placebo-controlled phase 2 RCT n = 290 |
Clinical endpoint evaluation | Failed to show clinical efficacy in large-scale blinded psychiatric trial. |
Regulatory Status & Clinical Safety
Regulatory Classification
FDA approved (NDA 018261) for induction/augmentation of labor and postpartum hemorrhage control.
Safety Realities & Impurities
Safety depends on the molecule, formulation, route and evidence. A laboratory purity measurement alone cannot establish safety for human use.
Clinical Trials Registry Records
Official registry records from ClinicalTrials.gov. Study registration does not imply government endorsement or guaranteed efficacy.
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS) [2]
- Planned enrollment
- 290 (patients)
- Posted results
- Available
- Sponsor
- Duke University / NICHD
- Last updated
- 2021
WADA & Anti-Doping Regulations
WADA Anti-Doping Status
Oxytocin is not prohibited under current World Anti-Doping Agency (WADA) regulations. However, athletes must ensure unregulated preparations or unverified vendor products do not violate Section S0 (Non-approved substances). Last verified: October 2026.
Research Timeline
-
1906
Discovery
Sir Henry Dale discovers uterine contractile properties of posterior pituitary extract. [7]
-
1953
Chemical Synthesis
Vincent du Vigneaud determines sequence and synthesizes oxytocin (Nobel Prize 1955). [3]
-
1955
FDA Approval
Synthetic oxytocin approved for commercial clinical use. [5]
-
2021
Psychiatric Limits
NEJM publishes definitive pediatric autism trial showing no social endpoint separation. [2]
What Researchers Still Don't Know
Long-term safety profiles
Multi-year observational data in broader heterogeneous cohorts remains uncharacterized.
Optimal dose-response thresholds
Comparative trials optimizing minimal effective exposure versus adverse event rates.
Formulation bioavailability
Differences between oral, subcutaneous, and modified peptide delivery vehicles.
References
Primary sources verified against PubMed / NLM and regulatory databases.
- Systematic Review & Meta-Analysis
-
Multicenter RCT
Intranasal oxytocin in children and adolescents with autism spectrum disorder ↗ (external website)
-
Biochemical Landmark
The synthesis of an octapeptide amide with the hormonal activity of oxytocin ↗ (external website)
-
Neuroimaging Study
Oxytocin modulates neural circuitry for social cognition and fear in humans ↗ (external website)
-
FDA Drug Label
Pitocin (Oxytocin Injection) FDA Prescribing Information ↗ (external website)
-
Review
The oxytocin receptor system: structure, function, and regulation ↗ (external website)
- Historical Landmark
